Requires health insurance providers to provide insurance coverage for pharmacists’ services.
S0897 requires health insurance coverage for a range of pharmacists’ services when those services would be covered if performed by a physician, advanced practice nurse, or physician assistant. The bill applies to group health insurance contracts and related medical policies issued, delivered, or renewed in Rhode Island on or after January 1, 2026, and it specifically identifies covered pharmacist services such as patient evaluation and management, medication therapy management, immunization education and administration, medication administration, and ordering and evaluating clinical laboratory tests. It also covers pharmacists acting under collaborative practice agreements.
The bill applies this coverage mandate across several insurance categories, including accident and sickness policies, nonprofit hospital service corporations, nonprofit medical service corporations, and health maintenance organizations. It also directs the state’s Medicaid administration to establish comparable coverage and to seek any necessary federal approval or waiver, with a Medicaid state plan amendment due by September 1, 2025. The act would take effect January 1, 2026, and would sunset on January 1, 2030 unless extended by the General Assembly.
The bill would amend multiple chapters of Rhode Island insurance law to add a new statutory coverage requirement for pharmacists’ services, and it would also direct the executive office of health and human services to implement similar coverage in Medicaid. Insurers would be required to include pharmacists in provider networks, and they could not condition reimbursement on supervision, signature, or referral by another provider, though they would not have to pay for duplicative services already rendered by another clinician. The bill limits the mandate to services within network, except where the needed service is unavailable in-network. It creates a temporary statewide policy that would expire in 2030 unless renewed.
Based on the bill text and available context, the measure appears generally supportive of expanding pharmacists’ role in patient care and reimbursement. The proposal is framed as a coverage expansion rather than a restriction, and there is no recorded committee transcript or vote history in the provided materials indicating formal opposition or amendment debate. The inclusion of a sunset date suggests an effort to make the policy temporary or pilot-like, which may reflect an intent to evaluate its effects before permanent adoption.
The main policy issue is whether pharmacists should be reimbursed directly by health plans for clinical services traditionally associated with physicians, nurse practitioners, or physician assistants. Potential points of contention include insurer concerns about added costs, network adequacy requirements, and the prohibition on requiring supervision or referral as a condition of payment. Another likely issue is avoiding payment for duplicative services when both a pharmacist and another provider render the same service. The bill also raises implementation questions for Medicaid, including federal approval and waiver requirements.